Table of Contents
Journal of Biomarkers
Volume 2016 (2016), Article ID 5643853, 6 pages
http://dx.doi.org/10.1155/2016/5643853
Research Article

Determination of Urinary Neopterin/Creatinine Ratio to Distinguish Active Tuberculosis from Latent Mycobacterium tuberculosis Infection

1Luton & Dunstable University Hospital NHS Foundation Trust, London LU4 ODZ, UK
2Institute of Child Health, University College London, London WC1N 1EH, UK

Received 2 March 2016; Revised 8 May 2016; Accepted 19 May 2016

Academic Editor: Mark Molloy

Copyright © 2016 Michael Eisenhut et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Harari, V. Rozot, F. Bellutti Enders et al., “Dominant TNF-α+Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease,” Nature Medicine, vol. 17, no. 3, pp. 372–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Sester, M. Fousse, J. Dirks et al., “Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states,” PLoS ONE, vol. 6, no. 3, Article ID e17813, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Agranoff, D. Fernandez-Reyes, M. C. Papadopoulos et al., “Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum,” The Lancet, vol. 368, no. 9540, pp. 1012–1021, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Eisenhut, “Neopterin in diagnosis and monitoring of infectious diseases,” Journal of Biomarkers, vol. 2013, Article ID 196432, 10 pages, 2013. View at Publisher · View at Google Scholar
  5. J. Westermann, F. Thiemann, L. Gerstner et al., “Evaluation of a new simple and rapid enzyme-linked immunosorbent assay kit for neopterin determination,” Clinical Chemistry and Laboratory Medicine, vol. 38, no. 4, pp. 345–353, 2000. View at Google Scholar · View at Scopus
  6. S. Buehrer-Sekula, F. F. V. Hamerlinck, T. A. Out, L. G. Bordewijk, and P. R. Klatser, “Simple dipstick assay for semi-quantitative detection of neopterin in sera,” Journal of Immunological Methods, vol. 238, no. 1-2, pp. 55–58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Yuksekol, M. Ozkan, O. Akgul et al., “Urinary neopterin measurement as a non-invasive diagnostic method in pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 8, pp. 771–776, 2003. View at Google Scholar · View at Scopus
  8. R. S. Wallis, T. M. Doherty, P. Onyebujoh et al., “Biomarkers for tuberculosis disease activity, cure, and relapse,” The Lancet Infectious Diseases, vol. 9, no. 3, pp. 162–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. National Institute for Health and Clinical Excellence, Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. (Clinical Guideline117), NICE, 2011, https://www.nice.org.uk/guidance/CG117.
  10. V. Guyot-Revol, J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani, “Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 7, pp. 803–810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Fuchs, A. Hausen, M. Kofler, H. Kosanowski, G. Reibnegger, and H. Wachter, “Neopterin as an index of immune response in patients with tuberculosis,” Lung, vol. 162, no. 1, pp. 337–346, 1984. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Wachter, D. Fuchs, A. Hausen et al., Neopterin: Biochemistry, Methods, Clinical Application, Walter de Gruyter, Berlin, Germany, 1991.
  13. G. Reibnegger, D. Fuchs, A. Hausen et al., “Correlation of serum interferon-gamma and neopterin concentrations in Africans with various diseases,” Pteridines, vol. 1, no. 2, pp. 119–124, 1989. View at Publisher · View at Google Scholar
  14. M. Hosp, A. M. Elliott, J. G. Raynes et al., “Neopterin, β2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis,” Lung, vol. 175, no. 4, pp. 265–275, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. Sealed Envelope, “Power calculator for continuous outcome equivalence trial,” 2012, http://www.sealedenvelope.com/power/continuous-equivalence/.
  16. J. Lacronique, A. Auzeby, D. Valeyre et al., “Urinary neopterin in pulmonary sarcoidosis. Relationship to clinical and biologic assessment of the disease,” American Review of Respiratory Disease, vol. 139, no. 6, pp. 1474–1478, 1989. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Sucher, K. Schroecksnadel, G. Weiss, R. Margreiter, D. Fuchs, and G. Brandacher, “Neopterin, a prognostic marker in human malignancies,” Cancer Letters, vol. 287, no. 1, pp. 13–22, 2010. View at Publisher · View at Google Scholar · View at Scopus